Immunosuppressive therapy as first-line and relapse treatment in paediatric subcutaneous panniculitis-like T-cell lymphoma.
No abstract available
References:
Guenova E, Schanz S, Hoetzenecker W, DeSimone JA, Mehra T, Voykov B, et al. Systemic corticosteroids for subcutaneous panniculitis‐like T‐cell lymphoma. Br J Dermatol. 2014;171(4):891–894.
Medhi K, Kumar R, Rishi A, Kumar L, Bakhshi S. Subcutaneous panniculitislike T‐cell lymphoma with hemophagocytosis: complete remission with BFM‐90 protocol. J Pediatr Hematol Oncol. 2008;30(7):558–561.
Asati DP, Ingle V, Joshi D, Tiwari A. Subcutaneous panniculitis‐like T‐cell lymphoma with macrophage activation syndrome treated by cyclosporine and prednisolone. Indian Dermatol Online J. 2016;7(6):529–532.
Duan Y, Gao H, Zhou C, Jin L, Yang J, Huang S, et al. A retrospective study of 18 children with subcutaneous panniculitis‐like T‐cell lymphoma: multidrug combination chemotherapy or immunomodulatory therapy? Orphanet J Rare Dis. 2022;17(1):432.
Guitart J, Mangold AR, Martinez‐Escala ME, Walker CJ, Comfere NI, Pulitzer M, et al. Clinical and pathological characteristics and outcomes among patients with subcutaneous panniculitis‐like T‐cell lymphoma and related adipotropic lymphoproliferative disorders. JAMA Dermatol. 2022;158(10):1167–1174.